Cerebral Oxygenation Values in Healthy Adults Volunteers Measured With RheoPatch and NIRO-200NX

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

May 10, 2023

Conditions
HealthyAdults
Interventions
DEVICE

Cerebral oximetry using Rheopatch

"On the study visit, baseline demographic data (age and gender, BMI) are collected. In supine position the sensor patches (left and right) of the device are applied to the forehead and the cerebral oxymetry values are recorded during 120sec. The sensor patches are then removed and the patches of the second device are applied on the same position on the forehead and the measurement is carried out as described before. For the first measurement of each sensor, a total of 5 minutes equilibration and sensor output power adjustment is allowed. A total of 10 measurements are taken, 5 with each device.~The volunteer is then placed in Trendelenburg position and another 4 measurements are made (2 with each device) as previously described."

DEVICE

Cerebral oximetry using NIRO-200NX

"On the study visit, baseline demographic data (age and gender, BMI) are collected. In supine position the sensor patches (left and right) of the device are applied to the forehead and the cerebral oxymetry values are recorded during 120sec. The sensor patches are then removed and the patches of the second device are applied on the same position on the forehead and the measurement is carried out as described before. For the first measurement of each sensor, a total of 5 minutes equilibration and sensor output power adjustment is allowed. A total of 10 measurements are taken, 5 with each device.~The volunteer is then placed in Trendelenburg position and another 4 measurements are made (2 with each device) as previously described."

Trial Locations (1)

3010

Dep. Anesthesiology and Pain Therapy, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER